The U.S. House of Representatives passed the Food and Drug Amendments of 2022, which includes OoCs and Microphysiological Systems (MPSs) as independent systems for evaluating drugs in non-clinical trials

Release time:

2022-06-01 00:00

Source:

美国众议院通过《2022年食品和药品修正法案》，将器官芯片和微生理系统作为独立的药物非临床试验评估体系纳入法案

Previous Page

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

Organoid research has been approved as a key special project of the National Key R&D Program in China’s 14th Five-Year Plan

Next Page

Previous Page

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

Next Page

Organoid research has been approved as a key special project of the National Key R&D Program in China’s 14th Five-Year Plan

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement